Skip to main content
OpenTrials
Completed

NCT Number: NCT05736094

Ultrasound for Detection of Prostate Cancer

Clinical proof of concept of dual-frequency ultrasound imaging for detection and visualization of prostate cancer.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Prostate Cancer Genital Diseases Genital Diseases, Male Genital Neoplasms, Male Male Urogenital Diseases Neoplasms Neoplasms by Site Prostatic Diseases Prostatic Neoplasms Urogenital Diseases Urogenital Neoplasms

Age range

18 year and older

Sex eligibility

Male

Study type

Interventional

Phase

Not applicable

Primary location

Oslo University Hospital

Oslo, 0379, Norway

About this study

Prospectively recruited patients before prostatectomy and/or definitive radiotherapy will be included in the study. Dual-frequency ultrasound imaging will be compared to standard transrectal ultrasound and MRI. Imaging of primary tumor with dual-frequency ultrasound technology including the use of microbubble contrast-media.

A prostate biopsy and blood sample will be taken from each patient, for histopathology and explorative biomarkers.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Age 18 years onwards
  • Signed written informed consent to perform rectal and transperineal ultrasound

Exclusion criteria

  • N/A

Treatment and study plan

SURF

Device

Dual-frequency ultrasound

Primary outcomes

  1. Clinical proof of concept of dual-frequency ultrasound imaging for detection and visualization of prostate cancer.

    Time frame: 1 day

    Sensitivity and specificity outcome measures

  2. Clinical proof of concept of dual-frequency ultrasound imaging for detection and visualization of prostate cancer.

    Time frame: 1 day

    Comparing dual-frequency ultrasound, shear waves ultrasound, CEUS to MRI and histopathological findings

Sponsors and collaborators

Lead sponsor

Oslo University Hospital

Other

Collaborators

  • Norwegian University of Science and Technology
  • The Research Council of Norway
  • University of Oslo

Registry information

Official study title

Dual-frequency Ultrasound for Detection of Prostate Cancer

Acronym: SURF

Important dates

Study start
2023
Primary completion
2023
Study completion
2024
First posted
Feb 21, 2023
Registry last updated
Apr 5, 2024

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.